Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
about
Vitreous mediators in retinal hypoxic diseasesEndothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature ReviewIntravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathyIntravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6)Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy.The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in ratsDevelopmental regulation of NO-mediated VEGF-induced effects in the lung.Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic SubjectsMediators of ocular angiogenesis.Plasma and vitreous fluid levels of Dickkopf-1 in patients with diabetic retinopathy.The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes.Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia
P2860
Q27028225-FAFA48F0-86E2-4AF7-A1CF-D00557E84F04Q28071774-D83D1DDB-75C9-42CB-A9D3-5634C19CCC09Q33492339-542F4B00-5F91-4A54-9CDC-089DD626E28AQ34621295-0BB2A8DD-A331-47CE-AE73-37B4732D7F8EQ35459633-123F6ABA-5987-43A2-A5CC-5C4728BEF4B3Q35739660-D133E354-65D9-4A31-AF7D-835955B781DBQ36425846-968C76DA-052D-4C67-AC56-AC9FA1711F31Q36906436-13513379-D36F-463B-A1A4-F3C93EEB3CDDQ37071368-62C29EA9-2749-4EFC-A347-677E441590A5Q37545245-60DC4E30-A042-45A0-A45B-CC6066D2F402Q37678807-7721D86B-6D92-4888-8D98-17B293825D24Q37697860-3374B762-2246-49CD-9773-A2DF5106F32DQ50947386-E091F8DA-1C6E-410D-AEC2-20CF1DB48F32Q53637738-CCA3853C-3327-4E46-BBF6-D202572C5698Q58703191-39331B20-AEA9-4551-BC21-352449CB8574
P2860
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@en
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@nl
type
label
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@en
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@nl
prefLabel
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@en
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
@nl
P2093
P2860
P1476
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy
@en
P2093
A J M Boulton
J V Forrester
K C McHardy
P B Wilson
P2860
P304
P356
10.1111/J.1582-4934.2005.TB00499.X
P577
2005-07-01T00:00:00Z